Biocon Biologics receives USFDA approval for cancer drug Jobevne

The USFDA has approved the cancer treatment medication Jobevne, which has allowed Biocon Biologics, the biosimilar division of Biocon, to increase its oncology portfolio.

Government introduces new regulations for imported medicines

In order to prevent the sales of unapproved or illegal medicines in Indian market, import registration and license have been made mandatory by The Central Drugs Standard Control Organization. On April 8, the apex drug regulatory agency of India...

Trump Announces Upcoming Major Tariff on Pharmaceutical Imports

The United States president Donald Trump announced that the U.S will shortly introduce a "major" tariff on pharmaceutical imports. “We are going to be announcing very shortly a major tariff on

Obesity Drugs Gain Momentum in India as Market Grows Over Fourfold

The anti-obesity drug market in India experienced a remarkable fourfold increase from March 2021 to March 2025 according to PharmaTrac data with a value growth from ?133 crore to ?576 crore. The market points to lifestyle disorders as well as consume

Cadila Pharma Launches Vasograin EC with FDA-Approved Migraine Formula

The well-known migraine drug Vasograin has a new formulation called Vasograin EC, which was announced by Cadila Pharmaceuticals. The updated formulation is currently manufactured in a US FDA-approved facility that complies with global quality and....

UniSA Researchers Develop Quantum-Powered Laparoscopic Probe for GI Cancers

Researchers at the University of South Australia (UniSA) are working on a laparoscopic probe that uses quantum technology to enhance the detection of gastrointestinal cancers. Supported by the federal government's Economic Accelerator...

WHO Redesignates MHRA’s Science and Research Group as Collaborating Centre

The World Health Organization (WHO) has officially re-designated the Medicines and Healthcare products Regulatory Agency's (MHRA) Science and Research group as a Collaborating Centre for the Standardisation and Evaluation of Biologicals for...

CDSCO Releases SOPs for Transferring Drugs from SEZs to Domestic Markets

Standard Operating Procedures (SOP) have been framed by the CDSCO for drugs manufactured in Special Economic Zones for transfer...

Indian Pharma Stocks tumble as Trump Hints at Tariffs on Drug Imports

Donald Trump's remarks threatening massive tariffs on all imports of pharmaceuticals led to a crash in the Indian pharmaceutical stocks. The news unsettled the Indian...

Lyka Labs Secures Indian Patent for Pregabalin Gel for Neuropathic Pain

Lyka Labs Limited has revealed that it has received an Indian Patent for its unique product, Pregabalin Gel 8 percent, with patent protection lasting until 2043.

© 2025 India Pharma Outlook. All Rights Reserved.